Close Menu

Takara Bio

Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

A US district court has dismissed a lawsuit filed earlier this year against more than a dozen life science companies alleging that they falsely marked certain nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.

WaferGen Biosystems this week reported a nearly 10-fold year-over-year decline in second-quarter revenues due to an "absence of sales" of its SmartChip real-time PCR platform.

A group of researchers from Lawrence Livermore National Laboratory has demonstrated PCR amplification of nucleic acids in less than three minutes using typical microliter-scale reaction volumes.

The company will receive no proceeds from the offering but could receive $34.8 million if warrants included in the offering are exercised in full.

Pages

A new paper says an effort to introduce gene drives into mosquitos altered the genetic makeup of the local mosquitos, but the company behind the project says the paper is flawed.

Virginia's Department of Forensic Science is offering attorneys a course on DNA testing, the Virginian-Pilot reports.

Researchers examine changes in the genomes of emmer wheat populations where the climate has warmed, the BBC reports.

In Cell this week: microinjection of CRISPR-Cas9 enables targeted mutations in Anolis, melanoma proteomic profiling, and more.